Ondine Biomedical Inc. OBI.L Stock
Ondine Biomedical Inc. Price Chart
Ondine Biomedical Inc. OBI.L Financial and Trading Overview
| Ondine Biomedical Inc. stock price | 7.5 GBP |
| Previous Close | 15.5 GBP |
| Open | 15.9 GBP |
| Bid | 15 GBP x N/A |
| Ask | 16 GBP x N/A |
| Day's Range | 15.9 - 15.9 GBP |
| 52 Week Range | 13.6 - 45.65 GBP |
| Volume | 586 GBP |
| Avg. Volume | 29.65K GBP |
| Market Cap | 31.94M GBP |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.06 GBP |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
OBI.L Valuation Measures
| Enterprise Value | 18.41M GBP |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 50.060078 |
| Price/Book (mrq) | 265 |
| Enterprise Value/Revenue | 28.862 |
| Enterprise Value/EBITDA | -0.993 |
Trading Information
Ondine Biomedical Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -63.52% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 45.65 GBP |
| 52 Week Low | 13.6 GBP |
| 50-Day Moving Average | 17.02 GBP |
| 200-Day Moving Average | 22.19 GBP |
OBI.L Share Statistics
| Avg. Volume (3 month) | 29.65K GBP |
| Avg. Daily Volume (10-Days) | 31.91K GBP |
| Shares Outstanding | 194.59M |
| Float | 194.53M |
| Short Ratio | N/A |
| % Held by Insiders | 70.74% |
| % Held by Institutions | 10.73% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2940.90% |
| Gross Margin | 44.98% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -46.25% |
| Return on Equity (ttm) | -93.80% |
Income Statement
| Revenue (ttm) | 638K GBP |
| Revenue Per Share (ttm) | 0.003 GBP |
| Quarterly Revenue Growth (yoy) | -36.70% |
| Gross Profit (ttm) | N/A |
| EBITDA | -18544000 GBP |
| Net Income Avi to Common (ttm) | -19372000 GBP |
| Diluted EPS (ttm) | -0.06 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 13.13M GBP |
| Total Cash Per Share (mrq) | 0.07 GBP |
| Total Debt (mrq) | 1.38M GBP |
| Total Debt/Equity (mrq) | 11.83 GBP |
| Current Ratio (mrq) | 3.872 |
| Book Value Per Share (mrq) | 0.06 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -16345000 GBP |
| Levered Free Cash Flow (ttm) | -7877125 GBP |
Profile of Ondine Biomedical Inc.
| Country | United Kingdom |
| State | BC |
| City | Vancouver |
| Address | 1100 Melville Street |
| ZIP | V6E 4A6 |
| Phone | 604-669-0555 |
| Website | https://www.ondinebio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company's lead product is Steriwave, a photodisinfection-based medical device that eliminates harmful nasal pathogens, which leads to healthcare-associated infections. Its product pipeline also includes development of a topical antiviral therapy for the upper respiratory tract that reduces viral titres and transmission of respiratory viruses, such as SARS-CoV-2, influenza, RSV, etc.; a solution for treatment of chronic rhinosinusitis; a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.
Q&A For Ondine Biomedical Inc. Stock
What is a current OBI.L stock price?
Ondine Biomedical Inc. OBI.L stock price today per share is 7.5 GBP.
How to purchase Ondine Biomedical Inc. stock?
You can buy OBI.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ondine Biomedical Inc.?
The stock symbol or ticker of Ondine Biomedical Inc. is OBI.L.
Which industry does the Ondine Biomedical Inc. company belong to?
The Ondine Biomedical Inc. industry is Biotechnology.
How many shares does Ondine Biomedical Inc. have in circulation?
The max supply of Ondine Biomedical Inc. shares is 2.27M.
What is Ondine Biomedical Inc. Price to Earnings Ratio (PE Ratio)?
Ondine Biomedical Inc. PE Ratio is now.
What was Ondine Biomedical Inc. earnings per share over the trailing 12 months (TTM)?
Ondine Biomedical Inc. EPS is -0.06 GBP over the trailing 12 months.
Which sector does the Ondine Biomedical Inc. company belong to?
The Ondine Biomedical Inc. sector is Healthcare.